MOTS-c Dosing: Daily vs Weekly Protocol Comparison and What the Literature Suggests
Daily versus weekly MOTS-c dosing — pharmacokinetic reasoning, protocol conventions, cycling windows, and a practical decision framework.
The Case for Each Schedule
Research protocols for MOTS-c split into two camps. Weekly dosing (5-10 mg) is the dominant convention — it matches the single-dose human metabolic study's exposure profile, suits the peptide's sustained AMPK signaling, and minimizes injection burden. Daily microdosing (0.5-1 mg/day) circulates in longevity-community protocols, aiming for steady-state signaling mimicry of the natural peptide's role in constant metabolic regulation.
The pharmacokinetic case favors weekly: MOTS-c's effects on AMPK and metabolic genes persist days beyond detectable plasma levels, so frequent pulsing adds injection-site exposure without obviously adding signaling benefit. The counterargument favors daily: natural MOTS-c is a constitutively-present signaling peptide, and mimicking physiology might suit long-term research better than pulses.
There is no head-to-head human data. Neither schedule has trial support over the other — the choice is convention, mechanism reasoning, and personal research design.
Cycling Windows and Long-Term Protocols
Cycling logic for MOTS-c mirrors broader peptide research practice: 8-12 week protocol windows followed by 4-week washouts. The rationale is receptor/signaling sensitivity, and for MOTS-c specifically, avoiding the possibility that chronic exogenous AMPK activation downregulates the natural peptide's signaling. Evidence for downregulation is absent — the precaution is convention.
A representative structured research protocol: weeks 1-12 dosing, weeks 13-16 washout with labs at weeks 0, 12, and 16. Metrics: fasting glucose, insulin, HbA1c, lipid panel, resting HR, training logs. This produces a dataset that says something — unlike indefinite use with no endpoints, which is consumption, not research.
The Math Either Way
Daily or weekly, reconstitution discipline is identical. Worked example for weekly: 10 mg vial, 2 mL bac water → 5 mg/mL. A 7.5 mg research dose = 1.5 mL. A daily 0.7 mg microdose from the same vial = 0.14 mL — small enough that syringe tick-mark precision matters, and 30 days of daily dosing consumes the vial in ~2 weeks. Our [peptide reconstitution calculator] handles both schedules, converting mg targets into mL and insulin-syringe units for any vial size and dilution. The [MOTS-c dosing guide] covers the full protocol landscape, and the cost calculator compares per-protocol economics across vendors.
📊 Dosage Calculator & Protocol Chart
Use our free MOTS-c dosage calculator to plan your protocol:
👉 MOTS-c Dosage Calculator — Calculate exact dosing, reconstitution ratios, and injection volumes.
👉 Full Dosing Guide & Protocol Chart — Complete protocol with weekly titration schedule, side effect management, and cycle recommendations.
Important Disclaimer
This article is for educational and research purposes only. Peptides discussed may not be FDA-approved for all uses described. Always consult with a qualified healthcare provider before starting any peptide protocol. The information provided here is synthesized from published research, clinical trial data, and community discussions.
Keywords: MOTS-c daily vs weekly, MOTS-c cycling protocol, MOTS-c microdosing, peptide dosing frequency, MOTS-c washout
Sources: Published research papers, clinical trial databases, community discussions, peptiq.io educational content